Dr Steven A Muhle, MD - Medicare Emergency Medicine in Weston, WI

Dr Steven A Muhle, MD is a medicare enrolled "Emergency Medicine" physician in Weston, Wisconsin. His current practice location is 3400 Ministry Pkwy, Weston, Wisconsin. You can reach out to his office (for appointments etc.) via phone at (715) 393-3000.

Dr Steven A Muhle is licensed to practice in Wisconsin (license number 48075) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1174561195.

Contact Information

Dr Steven A Muhle, MD
3400 Ministry Pkwy,
Weston, WI 54476-5220
(715) 393-3000
Not Available



Physician's Profile

Full NameDr Steven A Muhle
GenderMale
SpecialityEmergency Medicine
Location3400 Ministry Pkwy, Weston, Wisconsin
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1174561195
  • Provider Enumeration Date: 06/03/2006
  • Last Update Date: 03/07/2023
  Medicare PECOS Information:
  • PECOS PAC ID: 6204886377
  • Enrollment ID: I20050804001093

Medical Identifiers

Medical identifiers for Dr Steven A Muhle such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1174561195NPI-NPPES
34657100MedicaidWI

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207P00000XEmergency Medicine 48075 (Wisconsin)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Steven A Muhle allows following entities to bill medicare on his behalf.
Entity NameMarshfield Clinic Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1952347981
PECOS PAC ID: 2264345206
Enrollment ID: O20031106000590

News Archive

Researchers use new method to deliver anti-cancer drug to suppress tumor growth

Targeting drugs to cancer tissues is a major challenge in cancer treatment. Mesenchymal stem cells (MSCs) are known for their ability to find and target tumor cells in the body, but using MSCs for drug delivery has been tricky, because upon loading with drugs, MSCs lose their viability and migratory ability.

Ground breaking study dispels myth that vitamin D2 and D3 have same nutritional value

Worldwide health authorities are being urged to rethink official guidance around vitamin D following the publication of a ground breaking study from the University of Surrey, which dispels the myth that vitamin D2 and D3 have the same nutritional value.

Dispute over malaria figures highlights lack of certainty in data in age of 'information overload'

In this post in TIME World's "Global Spin" blog, TIME's Africa bureau chief Alex Perry examines questions surrounding an Institute for Health Metrics and Evaluation (IHME) study published in the Lancet on Friday that suggests "malaria kills almost twice as many people a year as previously believed."

Interim analysis of AIM-HIGH study affirms positive impact of Niaspan on HDL and triglyceride lipid values

The National Heart, Lung and Blood Institute (NHLBI), a division of the National Institutes of Health (NIH), disclosed results from an interim analysis of the AIM-HIGH clinical trial.

Study reveals protective potential of all three major immunoglobulin isotypes against SARS-CoV-2

In a recent medRxiv preprint paper, researchers from Mount Sinai in New York showed that all three major immunoglobulin isotypes (IgM, IgG, and IgA) produced by our immune cells were capable of mediating neutralization of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, neutralization titers correlated much better with binding levels of IgM and IgA1 than IgG.

Read more Medical News

› Verified 2 days ago

Entity NameAspirus Merrill Hospital & Clinics Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1124084678
PECOS PAC ID: 0143117556
Enrollment ID: O20040301001179

News Archive

Researchers use new method to deliver anti-cancer drug to suppress tumor growth

Targeting drugs to cancer tissues is a major challenge in cancer treatment. Mesenchymal stem cells (MSCs) are known for their ability to find and target tumor cells in the body, but using MSCs for drug delivery has been tricky, because upon loading with drugs, MSCs lose their viability and migratory ability.

Ground breaking study dispels myth that vitamin D2 and D3 have same nutritional value

Worldwide health authorities are being urged to rethink official guidance around vitamin D following the publication of a ground breaking study from the University of Surrey, which dispels the myth that vitamin D2 and D3 have the same nutritional value.

Dispute over malaria figures highlights lack of certainty in data in age of 'information overload'

In this post in TIME World's "Global Spin" blog, TIME's Africa bureau chief Alex Perry examines questions surrounding an Institute for Health Metrics and Evaluation (IHME) study published in the Lancet on Friday that suggests "malaria kills almost twice as many people a year as previously believed."

Interim analysis of AIM-HIGH study affirms positive impact of Niaspan on HDL and triglyceride lipid values

The National Heart, Lung and Blood Institute (NHLBI), a division of the National Institutes of Health (NIH), disclosed results from an interim analysis of the AIM-HIGH clinical trial.

Study reveals protective potential of all three major immunoglobulin isotypes against SARS-CoV-2

In a recent medRxiv preprint paper, researchers from Mount Sinai in New York showed that all three major immunoglobulin isotypes (IgM, IgG, and IgA) produced by our immune cells were capable of mediating neutralization of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, neutralization titers correlated much better with binding levels of IgM and IgA1 than IgG.

Read more Medical News

› Verified 2 days ago

Entity NameHoward Young Medical Center Inc Of Woodruff Wisconsin
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1184673352
PECOS PAC ID: 4183519606
Enrollment ID: O20040419000970

News Archive

Researchers use new method to deliver anti-cancer drug to suppress tumor growth

Targeting drugs to cancer tissues is a major challenge in cancer treatment. Mesenchymal stem cells (MSCs) are known for their ability to find and target tumor cells in the body, but using MSCs for drug delivery has been tricky, because upon loading with drugs, MSCs lose their viability and migratory ability.

Ground breaking study dispels myth that vitamin D2 and D3 have same nutritional value

Worldwide health authorities are being urged to rethink official guidance around vitamin D following the publication of a ground breaking study from the University of Surrey, which dispels the myth that vitamin D2 and D3 have the same nutritional value.

Dispute over malaria figures highlights lack of certainty in data in age of 'information overload'

In this post in TIME World's "Global Spin" blog, TIME's Africa bureau chief Alex Perry examines questions surrounding an Institute for Health Metrics and Evaluation (IHME) study published in the Lancet on Friday that suggests "malaria kills almost twice as many people a year as previously believed."

Interim analysis of AIM-HIGH study affirms positive impact of Niaspan on HDL and triglyceride lipid values

The National Heart, Lung and Blood Institute (NHLBI), a division of the National Institutes of Health (NIH), disclosed results from an interim analysis of the AIM-HIGH clinical trial.

Study reveals protective potential of all three major immunoglobulin isotypes against SARS-CoV-2

In a recent medRxiv preprint paper, researchers from Mount Sinai in New York showed that all three major immunoglobulin isotypes (IgM, IgG, and IgA) produced by our immune cells were capable of mediating neutralization of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, neutralization titers correlated much better with binding levels of IgM and IgA1 than IgG.

Read more Medical News

› Verified 2 days ago

Entity NameAspirus Eagle River Hospital & Clinics, Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1346204385
PECOS PAC ID: 1658361951
Enrollment ID: O20040518000233

News Archive

Researchers use new method to deliver anti-cancer drug to suppress tumor growth

Targeting drugs to cancer tissues is a major challenge in cancer treatment. Mesenchymal stem cells (MSCs) are known for their ability to find and target tumor cells in the body, but using MSCs for drug delivery has been tricky, because upon loading with drugs, MSCs lose their viability and migratory ability.

Ground breaking study dispels myth that vitamin D2 and D3 have same nutritional value

Worldwide health authorities are being urged to rethink official guidance around vitamin D following the publication of a ground breaking study from the University of Surrey, which dispels the myth that vitamin D2 and D3 have the same nutritional value.

Dispute over malaria figures highlights lack of certainty in data in age of 'information overload'

In this post in TIME World's "Global Spin" blog, TIME's Africa bureau chief Alex Perry examines questions surrounding an Institute for Health Metrics and Evaluation (IHME) study published in the Lancet on Friday that suggests "malaria kills almost twice as many people a year as previously believed."

Interim analysis of AIM-HIGH study affirms positive impact of Niaspan on HDL and triglyceride lipid values

The National Heart, Lung and Blood Institute (NHLBI), a division of the National Institutes of Health (NIH), disclosed results from an interim analysis of the AIM-HIGH clinical trial.

Study reveals protective potential of all three major immunoglobulin isotypes against SARS-CoV-2

In a recent medRxiv preprint paper, researchers from Mount Sinai in New York showed that all three major immunoglobulin isotypes (IgM, IgG, and IgA) produced by our immune cells were capable of mediating neutralization of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, neutralization titers correlated much better with binding levels of IgM and IgA1 than IgG.

Read more Medical News

› Verified 2 days ago

Entity NameAspirus Stevens Point Hospital & Clinics, Inc.
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1538112230
PECOS PAC ID: 1850358938
Enrollment ID: O20041210000558

News Archive

Researchers use new method to deliver anti-cancer drug to suppress tumor growth

Targeting drugs to cancer tissues is a major challenge in cancer treatment. Mesenchymal stem cells (MSCs) are known for their ability to find and target tumor cells in the body, but using MSCs for drug delivery has been tricky, because upon loading with drugs, MSCs lose their viability and migratory ability.

Ground breaking study dispels myth that vitamin D2 and D3 have same nutritional value

Worldwide health authorities are being urged to rethink official guidance around vitamin D following the publication of a ground breaking study from the University of Surrey, which dispels the myth that vitamin D2 and D3 have the same nutritional value.

Dispute over malaria figures highlights lack of certainty in data in age of 'information overload'

In this post in TIME World's "Global Spin" blog, TIME's Africa bureau chief Alex Perry examines questions surrounding an Institute for Health Metrics and Evaluation (IHME) study published in the Lancet on Friday that suggests "malaria kills almost twice as many people a year as previously believed."

Interim analysis of AIM-HIGH study affirms positive impact of Niaspan on HDL and triglyceride lipid values

The National Heart, Lung and Blood Institute (NHLBI), a division of the National Institutes of Health (NIH), disclosed results from an interim analysis of the AIM-HIGH clinical trial.

Study reveals protective potential of all three major immunoglobulin isotypes against SARS-CoV-2

In a recent medRxiv preprint paper, researchers from Mount Sinai in New York showed that all three major immunoglobulin isotypes (IgM, IgG, and IgA) produced by our immune cells were capable of mediating neutralization of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, neutralization titers correlated much better with binding levels of IgM and IgA1 than IgG.

Read more Medical News

› Verified 2 days ago

Entity NameMchs Hospitals Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1093221434
PECOS PAC ID: 5698071173
Enrollment ID: O20180208000096

News Archive

Researchers use new method to deliver anti-cancer drug to suppress tumor growth

Targeting drugs to cancer tissues is a major challenge in cancer treatment. Mesenchymal stem cells (MSCs) are known for their ability to find and target tumor cells in the body, but using MSCs for drug delivery has been tricky, because upon loading with drugs, MSCs lose their viability and migratory ability.

Ground breaking study dispels myth that vitamin D2 and D3 have same nutritional value

Worldwide health authorities are being urged to rethink official guidance around vitamin D following the publication of a ground breaking study from the University of Surrey, which dispels the myth that vitamin D2 and D3 have the same nutritional value.

Dispute over malaria figures highlights lack of certainty in data in age of 'information overload'

In this post in TIME World's "Global Spin" blog, TIME's Africa bureau chief Alex Perry examines questions surrounding an Institute for Health Metrics and Evaluation (IHME) study published in the Lancet on Friday that suggests "malaria kills almost twice as many people a year as previously believed."

Interim analysis of AIM-HIGH study affirms positive impact of Niaspan on HDL and triglyceride lipid values

The National Heart, Lung and Blood Institute (NHLBI), a division of the National Institutes of Health (NIH), disclosed results from an interim analysis of the AIM-HIGH clinical trial.

Study reveals protective potential of all three major immunoglobulin isotypes against SARS-CoV-2

In a recent medRxiv preprint paper, researchers from Mount Sinai in New York showed that all three major immunoglobulin isotypes (IgM, IgG, and IgA) produced by our immune cells were capable of mediating neutralization of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, neutralization titers correlated much better with binding levels of IgM and IgA1 than IgG.

Read more Medical News

› Verified 2 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Steven A Muhle is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Steven A Muhle, MD
Po Box 78758,
Milwaukee, WI 53278-0758

Ph: (800) 818-6961
Dr Steven A Muhle, MD
3400 Ministry Pkwy,
Weston, WI 54476-5220

Ph: (715) 393-3000

News Archive

Researchers use new method to deliver anti-cancer drug to suppress tumor growth

Targeting drugs to cancer tissues is a major challenge in cancer treatment. Mesenchymal stem cells (MSCs) are known for their ability to find and target tumor cells in the body, but using MSCs for drug delivery has been tricky, because upon loading with drugs, MSCs lose their viability and migratory ability.

Ground breaking study dispels myth that vitamin D2 and D3 have same nutritional value

Worldwide health authorities are being urged to rethink official guidance around vitamin D following the publication of a ground breaking study from the University of Surrey, which dispels the myth that vitamin D2 and D3 have the same nutritional value.

Dispute over malaria figures highlights lack of certainty in data in age of 'information overload'

In this post in TIME World's "Global Spin" blog, TIME's Africa bureau chief Alex Perry examines questions surrounding an Institute for Health Metrics and Evaluation (IHME) study published in the Lancet on Friday that suggests "malaria kills almost twice as many people a year as previously believed."

Interim analysis of AIM-HIGH study affirms positive impact of Niaspan on HDL and triglyceride lipid values

The National Heart, Lung and Blood Institute (NHLBI), a division of the National Institutes of Health (NIH), disclosed results from an interim analysis of the AIM-HIGH clinical trial.

Study reveals protective potential of all three major immunoglobulin isotypes against SARS-CoV-2

In a recent medRxiv preprint paper, researchers from Mount Sinai in New York showed that all three major immunoglobulin isotypes (IgM, IgG, and IgA) produced by our immune cells were capable of mediating neutralization of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, neutralization titers correlated much better with binding levels of IgM and IgA1 than IgG.

Read more News

› Verified 2 days ago


Emergency Medicine Doctors in Weston, WI

Dr. Richard Eric Minnihan, M.D.
Emergency Medicine
Medicare: Medicare Enrolled
Practice Location: 3301 Cranberry Blvd, Weston, WI 54476
Phone: 715-393-3900    
Michael J Trobec, D.O.
Emergency Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 3501 Cranberry Blvd, Weston, WI 54476
Phone: 715-393-1000    
Dr. Peter G Topis, DO
Emergency Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 3400 Ministry Pkwy, Weston, WI 54476
Phone: 715-393-1000    
Dr. Thevalojini Thayaparan, MD
Emergency Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 3400 Ministry Pkwy, Weston, WI 54476
Phone: 715-393-3000    
Dr. Ellen J Westdorp, M.D.
Emergency Medicine
Medicare: Medicare Enrolled
Practice Location: 3400 Ministry Pkwy, Weston, WI 54476
Phone: 715-393-3000    
Dr. Jonathan Tyler Laack, D.O.
Emergency Medicine
Medicare: Medicare Enrolled
Practice Location: 3400 Ministry Pkwy, Weston, WI 54476
Phone: 715-393-3000    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.